Press Releases
-
Jumo Health Honored in Inc.’s Inaugural Power Partner Awards
Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.
Nov 1, 2022
-
Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits
-
Creative Enzymes Expands Its Probiotic Portfolio
-
Rising Prevalence of Isotope Labeling Carbohydrates Drives Innovations at BOC Sciences
BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.
Nov 1, 2022
-
BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.
Nov 1, 2022
-
BOC Sciences Makes Easy Access to Polymerization Tech
Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.
Nov 1, 2022
-
BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.
Nov 1, 2022
-
Metatranscriptome Analysis Service Is Now Available at CD Genomics
-
Meet CD Genomics at the SITC 37th Annual Meeting
-
Expanded Offering of Fatty Amines for Diverse Applications
-
Creative Biogene Develops Custom Lentivirus Services to Support Stable Cell Line Generation
-
Microbiosci Releases LPS Extraction Service to Support Managing Endotoxins Issues
-
Creative Biogene Delivers Knockout Mouse Models to Support Gene Editing and Future Studies
-
Nanoparticle Development Services for Drug Delivery System Research
-
Acylation Reagents for Gas Chromatography and Other Instrumental Analytical Methods
-
ExoQuali Products and Protocols Released by Creative Bioarray to Easy Exosome Isolation Process
-
Histobiolab Provides Over 150 Fish Probes to Satisfy Precise Biological Research Needs
-
Creative Bioarray Provides 3D Cell Patterning Service Based to Speed up Drug Screening
-
Press Release: Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.
Oct 30, 2022
-
Elligo Health Research® Named One of Central Texas’ Fastest-Growing Companies